PLTR vs SUPN · P/E 584, rev $4.48B vs rev $661.8M
Palantir Technologies Inc. Class A Common Stock (PLTR) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported PLTR revenue for 2025-12-31 was $4.48B. Net income was $1.63B. Revenue was up 56.2% from 2024-12-31 to 2025-12-31. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Latest reported SUPN revenue for 2024-12-31 was $661.8M. Net income was $73.9M. Revenue was up 8.9% from 2023-12-31 to 2024-12-31. SUPN currently screens at market cap $2.53B.
PLTR currently screens at market cap $317.08B and trailing P/E 584.2. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the PLTR and SUPN stock pages for the full models.
Not investment advice.